Trial intelligence / Profile preview

Effect of pregabalin in acute post-operative peripheral neuropathic pain (pilot)

2021-004417-40Phase 4Terminated

Sponsor
Helse Bergen
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of pregabalin in Peripheral neuropathic pain, sponsored by Helse Bergen. Primary endpoint: Pain intensity (Numeric Rating Scale). Started Nov 2021; status: terminated.

02

Drugs

pregabalin
03

Conditions

Peripheral neuropathic pain

Beyond the preview

Go deeper on 2021-004417-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-004417-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call